Involvement of hypothalamic nitric oxide signaling in the modulation of a rat's exercise capacity

Neuroreport. 2017 May 3;28(7):408-413. doi: 10.1097/WNR.0000000000000763.

Abstract

Purpose: The aim of this study was to explore the effect of nitric oxide (NO) in some regions of the hypothalamus on exercise capacity.

Materials and methods: To assess the role of central NO in exercise capacity, L-arginine (L-Arg, a precursor of NO synthesis), NG-nitro-L-arginine methyl ester (L-NAME, a NO synthase inhibitor), or placebo saline was injected into the lateral cerebral ventricle of rats once a day for 4 consecutive days. Thereafter, an one-time exhaustive treadmill exercise was performed, and the levels of nitrate/nitrite, as a marker of NO production, in blood plasma and hypothalamus were assayed. Neuronal nitric oxide synthase (nNOS)-expressing cells were immunohistochemically stained and analyzed in the paraventricular nucleus (PVN), the dorsomedial hypothalamus (DMH), and the ventromedial hypothalamus. Exercise time to exhaustion and total workload were determined.

Results: Compared with the rats in the saline group, the exercise time to exhaustion and total workload increased 50% in the L-Arg group and decreased 50% in the L-NAME group. The nitrate/nitrite level of hypothalamus in the L-Arg group increased 50% and decreased 29.4% in the L-NAME group. The number of nNOS-positive cells was significantly increased, 56.5%, in PVN and, 119%, in DMH, but not in ventromedial hypothalamus. No significant changes in nNOS-positive cells were found in L-NAME-treated rats.

Conclusion: These results show that the modulation of hypothalamic NO signaling can affect the rat's running performance during a treadmill exercise and that enhanced NO signaling by induction of nNOS in PVN and DMH plays a role in improving exercise capacity after central administration of L-Arg. NO signaling in PVN and DMH may be a useful target for the pharmacological intervention of exercise performance or capacity.

MeSH terms

  • Animals
  • Arginine / pharmacology
  • Catheters, Indwelling
  • Cell Count
  • Central Nervous System Agents / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Fatigue / metabolism
  • Fatigue / pathology
  • Fatigue / prevention & control
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism*
  • Hypothalamus / pathology
  • Immunohistochemistry
  • Male
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitrates / metabolism
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type I / metabolism
  • Nitrites / metabolism
  • Random Allocation
  • Rats, Sprague-Dawley
  • Running / physiology*

Substances

  • Central Nervous System Agents
  • Enzyme Inhibitors
  • Nitrates
  • Nitrites
  • Nitric Oxide
  • Arginine
  • Nitric Oxide Synthase Type I
  • Nos1 protein, rat
  • NG-Nitroarginine Methyl Ester